NIH Grant Reviewers Meet Behind Closed Virtual Doors
Published Date: 11/6/2026
Notice
Summary
The Center for Scientific Review at the NIH is holding several closed virtual meetings on December 2, 2026, to review important grant applications. These meetings protect private info and trade secrets while deciding which research projects get funding. Scientists applying for grants should note these dates as they impact who gets money for innovative health research.
No Economic Impacts Identified for this Document
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-22558, Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in early December 2026 to review and evaluate grant applications. These meetings affect researchers and small businesses seeking funding for health-related projects, ensuring privacy for sensitive information. No direct money changes are announced, but these reviews help decide who gets research grants.
2026-22550, Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding two closed virtual meetings on November 30, 2026, to review important grant applications. These meetings affect researchers applying for funding in cardiovascular sciences and tobacco regulatory science. No public access is allowed to protect private info and trade secrets, and the reviews help decide who gets research money.
2026-22339, Prospective Grant of Exclusive Patent License: Catheter-Based Intramyocardial Ablation for Treating Ventricular Arrhythmia in a Human
The National Institutes of Health plans to give AntaraCore Systems, Inc. an exclusive license to use new catheter technology that treats dangerous heart rhythm problems called ventricular arrhythmia. This means AntaraCore will have special rights to develop and sell this life-saving treatment. If you want to comment or apply for a license, you must do so by December 2, 2026.
2026-22196, National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Meeting
The National Institute of Diabetes and Digestive and Kidney Diseases is holding a public meeting on May 12, 2027, to discuss important council business and review grant applications. People interested can attend in person or online, but space is limited and some parts of the meeting will be private to protect sensitive information. This meeting affects researchers and organizations seeking funding and sets the stage for future diabetes and kidney disease research support.
2026-22114, Fogarty International Center; Notice of Meeting
The Fogarty International Center Advisory Board is meeting on June 7, 2027, both in-person and online to share updates and review important grant applications. This meeting affects researchers and organizations applying for funding, with some sessions open to the public and others closed to protect privacy and trade secrets. No registration is needed to join the open session, making it easy to stay informed about global health research funding.
2026-22111, Eunice Kennedy Shriver National Institute of Child Health & Human Development; Notice of Meeting
The Eunice Kennedy Shriver National Institute of Child Health & Human Development is holding a virtual meeting on June 4, 2027, to share updates and review grant applications and staff performance. The first half is open to the public, while the second half is private to protect personal privacy. This meeting affects researchers and staff involved with NICHD grants and projects, with no direct cost changes announced.
Previous / Next Documents
Previous: 2026-22661, Sunshine Act Meeting
The Consumer Product Safety Commission will hold a closed, remote meeting on November 10, 2026, to discuss important briefing matters. This affects anyone interested in product safety oversight but won’t involve public participation or immediate money changes. Stay tuned for updates on decisions that could impact consumer protections.
Next: 2026-22666, Wilkes-Barre Terminal Railway Company-Acquisition, Operation and Change of Operator Exemption-Luzerne County Redevelopment Authority and Luzerne County Rail Corporation, and R.J. Corman Railroad Company/Luzerne & Susquehanna Line, LLC
Wilkes-Barre Terminal Railway Company is stepping in to take over nearly 60 miles of rail lines in Luzerne County, Pennsylvania, from local authorities and will replace the current operator, R.J. Corman Railroad Company, on part of the route. This change means WBT will run the trains and manage the tracks, aiming for smoother rail service without any immediate cost changes announced. The switch is official as of November 2026, shaking up who’s in charge of these important local railroads.